Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Development: Bosch Presents Elematic 3001 Case Packer

Published: Monday, August 19, 2013
Last Updated: Monday, August 19, 2013
Bookmark and Share
Enhances user friendliness and hygiene.

At FachPack 2013 in Nuremberg, Germany, September 24 to 26 2013, Bosch Packaging Technology debuts its new Elematic 3001 case packer.

During the development and conceptual phase of the Elematic 3000’s successor, Bosch especially focused on enhanced ease of use and safety at the working place as well as increased production hygiene.

New design for increased safety and efficiency
Thanks to the new ergonomic design with a lowered carton magazine, manufacturers benefit from an easier and safer operation of the machine. In addition, the process of refilling the glue was optimized with an external hot glue tube which protects operators from burns.

Both features contribute to increased workplace safety and fulfill increasingly stringent regulations worldwide. Bernhard Vaihinger, head of product management, innovation and technology at Bosch Packaging Systems GmbH, a Bosch Packaging Technology company, highlights, “Manufacturers have to consider increasingly stringent legal requirements that are affecting packaging machinery design in terms of ergonomics and hygiene. At the same time, they cannot sacrifice productivity. Our new development enables manufacturers to achieve both.”

Format changeover with feedback
Similar to the Elematic series of secondary packaging machines from Bosch, the new Elematic 3001 can handle many different pack styles, including tray, classic full wrap-around and two-part, shelf-ready packaging. This is especially important for manufacturers supporting different brands and products with a variety of pack styles.

With the new Elematic 3001, easy and tool-less packaging format changeovers are realized thanks to a so-called “click-system”. When parts lock into place a sound indicates the successful format changeover. Manufacturers benefit from higher efficiency as time-consuming corrections are eliminated and errors while using scales are avoided.

Hygienic design enhances cleanability
Compared to previous models, Bosch further enhanced the machine’s hygienic design. With fewer components, the frame has an open design and is easily accessible. Horizontal surfaces and corners have been eliminated and corrosion-resistant materials, such as stainless steel, anodized aluminum or brass, are used.

In addition, all wiring and cables are hidden due to design-integrated conduits to protect them from dirt and damage. All features contribute to enhanced cleanability of the machine, which increases production hygiene.

Minimized maintenance reduces TCO
The minimized number of components and added new technologies, including servo drives, decrease maintenance work and reduce the Total Cost of Ownership (TCO) of the new Elematic 3001.

The incorporation of the total productive maintenance (TPM) concept indicates when maintenance is due, helping eliminate unplanned downtime, and increasing productivity.

To further reduce the footprint of the machine, the company integrated the control cabinet on board, which speeds up installation time at the customer’s plant.

In addition, thanks to the compact design of the machine, it meets the sea and air freight standards, decreasing overseas transportation costs.

The Elematic 3001 will be on display at Bosch’s Stand 305, Hall 4A of the Exhibition Centre, Nuremberg, September 24 to 26, 2013.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bosch Plans to Acquire Ampack Ammann
Extension of technological leadership in packaging of liquid and paste-like food.
Tuesday, July 24, 2012
Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!